Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Stroke - Sleep Disorders, Dysfunction of the Autonomic Nervous System and Depression

27. marts 2022 opdateret af: Helle Klingenberg Iversen, MD, DmSc
The purpose of this study is to investigate sleep disordered breathing, autonomic dysfunction, and post stroke depression in acute and chronic stroke patients. Furthermore, to explore the interaction between these comorbidities, and their relation to stroke aetiology.

Studieoversigt

Status

Afsluttet

Betingelser

Detaljeret beskrivelse

Up to fifty percent of stroke patients suffer less noticeable comorbidities after the acute phase of a stroke and often the rest of their life. It concerns sleep disordered breathing (SDB), post stroke depression (PSD), and dysfunction of the autonomic nervous system. These comorbidities are seldom recognized, but are associated with a poorer outcome after stroke, reduced quality of life as well as an increased risk of new vascular events.

Little is known about the course of the comorbidities, the relationship between the mentioned diseases or which patients are more commonly affected.

The investigators will investigate the following hypotheses, and assess the results compared to the stroke aetiology:

  1. Stroke patients with SDB have an impaired autonomic function
  2. Stroke patients with SDB have an increased risk of PSD
  3. Stroke patients with autonomic dysfunction have an increased risk of PSD

The investigators will examine stroke patients for signs of sleep disordered breathing, autonomic dysfunction and depression, both in the acute phase (days), in the chronic phase (months) and the very chronic state (years). Thereby the investigators can map the comorbidities course over time. At the same time the patients will be tested for peripheral small and large artery disease as well as MRI will be used to investigate sign of cerebral small vessel disease.

Based on power calculations 335 individuals will be enrolled in order to satisfy the project requirements.

Undersøgelsestype

Observationel

Tilmelding (Faktiske)

114

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Glostrup, Danmark, 2600
        • Department of clinical stroke research, department of neurology, Glostrup Hospital

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

The study population is recruited among patients admitted at the acute stroke unit at Glostrup university hospital.

Beskrivelse

Inclusion Criteria:

• Clinical stroke either ischaemic or haemorrhagic

Exclusion Criteria:

  • Transitory ischemic attac
  • Congenital or acquired brain disease, other than stroke
  • Dementia
  • Mental retardation
  • Fatal stroke or severe comorbidities with short expected life
  • Pregnancy or breastfeeding
  • Altered consciousness e.g. delirium or status epilepticus
  • Other cause of the patient, according to the investigator believes, can not complete the study

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: Kohorte
  • Tidsperspektiver: Fremadrettet

Kohorter og interventioner

Gruppe / kohorte
Acute stroke
No interventions. Only tests for depression, sleepapnea and autonomic dysfunction.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Sleep disordered breathing at any time after stroke.
Tidsramme: six month after stroke

The test for sleep disordered breathing will be performed within 7 days from stroke onset and after 6 month and five years.

Mild sleep apnea if AHI between 5 and 15, moderate sleep apnea if AHI between 15 and 30 and severe sleep apnea if AHI above 30. Subdivided into obstructive, central or mixed.

six month after stroke
Autonomic dysfunction at any time after stroke.
Tidsramme: six month after the stroke

The test for autonomic dysfunction will be performed within 7 days from stroke onset and after 6 month and five years.

Abnormal result of the valsalva manoeuvre, deep breathing, active standing or tilt table test. Improvement or worsening of the parameters like HRV, BRS and CO during the study period.

six month after the stroke
Depression at any time after stroke
Tidsramme: six month after the stroke

The test for depression will be performed within 7 days from stroke onset and after 6 month and five years.

Mild, moderate or severe depression according to HAM-D6, MDI or HADS

six month after the stroke

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Peripheral artery disease at any time after stroke
Tidsramme: six month after the stroke

The tests will be performed within 7 days from stroke onset and after 6 month and five years.

Stenosis of the carotid artery, abnormal ankle-brachial index or endothelial dysfunction.

six month after the stroke

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
New vascular episodes at any time after stroke
Tidsramme: Assessed at follow-up after six month
Assessed at follow-up after six month and five years. Stroke, TIA, acute coronary syndrome or operation for peripheral vascular disease.
Assessed at follow-up after six month
Death by cause at any time after stroke
Tidsramme: Assessed at follow-up after six month
Assessed at follow-up after six month and five years
Assessed at follow-up after six month

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Helle Iversen, MD, DMSc, Stroke research, Glostrup hospital

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. marts 2014

Primær færdiggørelse (Faktiske)

1. februar 2017

Studieafslutning (Faktiske)

1. marts 2022

Datoer for studieregistrering

Først indsendt

3. april 2014

Først indsendt, der opfyldte QC-kriterier

9. april 2014

Først opslået (Skøn)

11. april 2014

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

29. marts 2022

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

27. marts 2022

Sidst verificeret

1. marts 2022

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

Uafklaret

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner